BiotechTube
Home/Ophidion/Douglas Greene, M.D.
DG

Douglas Greene, M.D.

Chief Development Officer

Ophidion

Therapeutic Areas

Neurodegenerative DiseasesCentral Nervous System (CNS) Disorders

Ophidion Pipeline

DrugIndicationPhase
Platform-derived programsNeurodegenerative Diseases (unspecified)Preclinical

Leadership Team at Ophidion

YH
Yacoub Habib, Ph.D., MBA
Chief Executive Officer and Chairman of the Board
DJ
Douglas J. MacNeil, Ph.D.
VP of Preclinical Development
View full Ophidion profile